Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
7.38
+0.16 (2.22%)
At close: Dec 20, 2024, 4:00 PM
7.49
+0.11 (1.49%)
After-hours: Dec 20, 2024, 6:57 PM EST
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 557 employees as of December 31, 2023. The number of employees increased by 54 or 10.74% compared to the previous year.
Employees
557
Change (1Y)
54
Growth (1Y)
10.74%
Revenue / Employee
$163,120
Profits / Employee
-$736,081
Market Cap
2.25B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Addus HomeCare | 34,846 |
Ardent Health Partners | 23,000 |
CONMED | 4,000 |
Azenta | 3,300 |
Tandem Diabetes Care | 2,400 |
Geron | 141 |
IDEAYA Biosciences | 124 |
Centessa Pharmaceuticals | 76 |
IOVA News
- 1 day ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 25 days ago - Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer - GlobeNewsWire
- 5 weeks ago - Iovance Biotherapeutics Q3: A Beat, But A Selloff - Now A Buy Opportunity - Seeking Alpha
- 6 weeks ago - Iovance Biotherapeutics, Inc. (IOVA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024 - GlobeNewsWire
- 7 weeks ago - Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024 - GlobeNewsWire
- 2 months ago - Iovance Biotherapeutics: Moving To The Next Phase - Seeking Alpha
- 3 months ago - Iovance Biotherapeutics to Present at Upcoming Conferences - GlobeNewsWire